Hepatitis C Update: A Growing Challenge With Evolving Management Solutions
Source: Hepatitis C: Simplified Management From Screening to Cure

Interactive Virtual Presentation

In this updated CME-certified interactive presentation targeted to primary care clinicians, hepatitis expert Terry D. Box, MD, reviews the changing epidemiology of hepatitis C infections, age- and risk-based HCV screening, follow-up after testing in the primary care and specialist settings, and counseling patients on the benefits of HCV screening and treatment.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Apply current guidelines on age-cohort and risk-based HCV screening
  • Appropriately manage newly diagnosed and other untreated HCV patients, including staging and counseling them regarding the multiple health consequences of HCV infection
  • Accurately counsel patients regarding current HCV treatment options, including recommended timing of treatment and key characteristics of current regimens
  • Appropriately distinguish between HCV-infected patients who can be managed in primary care vs those requiring linkage to specialist care
CCO Interactive Virtual Presentations contain video commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.
 

Faculty

  • Terry D. Box
    MD
    Brian L. Pearlman
    MD, FACP, FAASLD
    Mary Speigle
    NP

Credit Information

  • Release Date:
    January 17, 2018
  • Expiration Date:
    January 16, 2019
  • Physicians:
    maximum of 0.75 AMA PRA Category 1 Credits

Information on this Educational Activity

STATEMENT OF DISCLOSURE AND INDEPENDENCE

It is the policy of Primary Care Network (PCN) to ensure all of its accredited educational activities are designed, implemented, and evaluated in accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Criteria and Policies. In accordance with ACCME requirements, PCN has Conflict of Interest (COI) and Disclosure Policies that are designed to ensure that PCN accredited educational activities are fair, balanced, independent, evidence based, and based on scientific rigor.

PCN’s Resolution of Personal COI Policy aims to ensure that all potential conflicts are identified and resolved prior to the activity, content is developed and presented free of commercial bias, and is in the interest of promoting improvements or quality in healthcare. All individuals who are in a position to influence and/or control content of a PCN accredited Continuing Medical Education (CME) activity are required to disclose to the participants any real or apparent conflict(s) of interest related to the activity. The educational content is also reviewed for independence and content validation by an independent clinical reviewer. Independence is also monitored through the activity and overall program evaluation process.

The opinions, ideas, recommendations, and perspectives expressed in the syllabus and accompanying presentation are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Primary Care Network, advisory boards and consultants, or the activity’s commercial supporter(s).

REVIEW COMMITTEE DISCLOSURES
In accordance with PCN policy, all content is reviewed by independent peer reviewers for balance, objectivity, and commercial bias.

It is the policy of Primary Care Network (PCN) to ensure all of its accredited educational activities are designed, implemented, and evaluated in accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Criteria and Policies. In accordance with ACCME requirements, PCN has Conflict of Interest (COI) and Disclosure Policies that are designed to ensure that PCN accredited educational activities are fair, balanced, independent, evidence based, and based on scientific rigor.

PCN’s Resolution of Personal COI Policy aims to ensure that all potential conflicts are identified and resolved prior to the activity, content is developed and presented free of commercial bias, and is in the interest of promoting improvements or quality in healthcare. All individuals who are in a position to influence and/or control content of a PCN accredited Continuing Medical Education (CME) activity are required to disclose to the participants any real or apparent conflict(s) of interest related to the activity. The educational content is also reviewed for independence and content validation by an independent clinical reviewer. Independence is also monitored through the activity and overall program evaluation process.

Faculty

Terry D. Box, MD


Associate Professor of Medicine
Division for Gastroenterology, Hepatology, Nutrition
University of Utah
Salt Lake City, Utah

Terry D. Box, MD, has disclosed that he has served on advisory boards for AbbVie, Bayer, Gilead Sciences, and Intercept; has received funds for research support from Gilead Sciences and Merck; and has served on speaker bureaus for Gilead Sciences.
 

Brian L. Pearlman, MD, FACP, FAASLD


Medical Director, Center for Hepatitis C
Wellstar Atlanta Medical Center
Atlanta, Georgia
Professor of Medicine
Medical College of Georgia
Augusta, Georgia
Associate Professor of Medicine
Emory School of Medicine
Atlanta, Georgia

Brian Pearlman, MD, has disclosed that he has served on advisory boards for Merck; has received funds for research support from AbbVie, Gilead Sciences, and Merck; and has served on speaker bureaus for AbbVie, Gilead Sciences, and Merck.
 

Mary Speigle, NP


Nurse Practitioner
Shasta Community Health Center
Redding, California

Mary Speigle, NP, has no relevant financial relationships to disclose.
 

Staff

Brian Koffman, MDCM


PCN Content Reviewer
Medical Director, CLL Society Inc.
Partner, St Jude Heritage Medical Group
Diamond Bar, California
Clinical Professor (Retired)
Department of Family Medicine
Keck School of Medicine, USC Family Practice
Los Angeles, California

Consultant: Ironwood, Janssen Pharmaceuticals, Inc. Stockholder: AbbVie, AstraZeneca, Bristol-Myers Squibb, Gilead Sciences, Mei Pharma, Sunesis, Verastem
 

Jill Hays, CHCP


PCN Content Reviewer
Executive Director
Primary Care Network
Springfield, Missouri

Jill Hays, CHCP, has no relevant financial relationships to disclose.
 

Cindy Fisher, 


CME Program Manager, PCN
Springfield, Missouri

Cindy Fisher has no relevant financial relationships to disclose.
 

Zachary Schwartz, MSc, ELS


Managing Editor

Zachary Schwartz, MSc, ELS, has no relevant financial relationships to disclose.
 

Megan Cartwright, PhD


Clinical Editor

Megan Cartwright, PhD, has no relevant financial relationships to disclose.
 

Jenny Schulz, PhD


Editorial Director, Virology & Other Therapeutic Areas

Jenny Schulz, PhD, has no relevant financial relationships to disclose.
 

Edward King, MA


Executive Vice President

Edward King, MA, has no relevant financial relationships to disclose.
 

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

The opinions, ideas, recommendations, and perspectives expressed in this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Primary Care Network, advisory boards or consultants.

 

Target Audience

This program is intended for internists, family physicians, nurse practitioners and physician assistants.


Goal

The goal of this activity is to improve primary care clinicians’ competence in the diagnosis and management of uncomplicated chronic hepatitis C infection.


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Apply current guidelines on age-cohort and risk-based HCV screening
  • Appropriately manage newly diagnosed and other untreated HCV patients, including staging and counseling them regarding the multiple health consequences of HCV infection
  • Accurately counsel patients regarding current HCV treatment options, including recommended timing of treatment and key characteristics of current regimens
  • Appropriately distinguish between HCV-infected patients who can be managed in primary care vs those requiring linkage to specialist care
 

Physician Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Primary Care Network (PCN) and Clinical Care Options. Primary Care Network is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Primary Care Network designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Commercial Support


This program is supported by an educational grant from Gilead Sciences.

 

Program Medium


This program has been made available online.

 

Site Requirements


  • Internet Explorer 7+, Firefox 3+, Safari 3+, or Chrome
  • JavaScript enabled
  • 1024x768+ screen resolution
  • Adobe Flash Player
 

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.75 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from January 17, 2018, through January 16, 2019:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 70% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME activities completed can be found on the "CME Manager" page. There are no costs/fees for this activity.